Treatment of childhood acute myeloid leukaemia

Bailliere's Clinical Haematology

Volumn 9, Issue 1, 1996, Pages 129-146

  Taub, J W ^a   Ravindranath, Y ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; AZACITIDINE; CLADRIBINE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FLUDARABINE; HYDROCORTISONE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHILDHOOD LEUKEMIA; DOWN SYNDROME; HUMAN; LEUKEMIA REMISSION; PRIORITY JOURNAL; REVIEW;

EID: 0029959013     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80040-0     Document Type: Review

References (86)

1. Amadori S Ceci A Comelli A Treatment of acute myelogenous leukemia in children: results of the Italian cooperative study AIEOP/LAM 8204 Journal of Clinical Oncology 5 1987 1356 1363
2. Amadori S Testi AM Aricò M Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia Journal of Clinical Oncology 11 1993 1046 1054
3. Avramis VI Mecum RA Nyce J Pharmacodynamic and DNA methylation studies of high-dose 1-β- d -arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia Cancer Chemotherapy and Pharmacology 24 1989 203 210
4. abstract No. 431 Bloomfield CD Lawrence D Arthur DC Curative impact of intensification with cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group Blood 84 1994 111a
5. Byrd JC Weiss RB Recurrent granulocytic sarcoma: an unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of neural cell adhesion molecules Cancer 73 1994 2107 2112
6. Cairo MS Siegel S Anas N Sender L Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors Cancer Research 49 1989 1063 1066
7. Carroll A Civin C Schneider N The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group study Blood 78 1991 748 752
8. Chard RL Finkelstein JZ Sonley MT Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy Medical and Pediatric Oncology 4 1978 263 273
9. Creutzig U Ritter J Riehm H Improved treatment results in childhood acute myelogenous leukemia: a report of the German Cooperative Study AML-BFM-78 Blood 65 1985 298 304
10. for the AML-BFM Study Group Creutzig U Ritter J Schellong G Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78 Blood 75 1990 1932 1940
11. Creutzig U Ritter J Zimmerman M Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the childhood Acute Myelogenous Leukemia Study BFM-87 Journal of Clinical Oncology 11 1993 279 286
12. abstract No. 44 Creutzig U Niemeyer C Stollmann-Gibbeh B Prognosis of children with Down Syndrome and acute myelogenous leukemia Proceedings of the American Association of Clinical Oncology 14 1995 10
13. abstract No. 767 Dahl G Dunussi K Mogul M A Pediatric Oncology Group (POG) phase II trial of mitoxantrone, etoposide and cyclosporine A (MEC) therapy for relapsed and refractory acute myelogenous leukemia Blood 82 1993 195a
14. abstract No. 205 Dinndorf PA Wiersma S Krailo M Phase I trial of idarubicin (IDA) given in combination with continuous infusion (CI) fludarabine (FLU) followed by CI Ara-C in relapsed leukemia: a Children's Cancer Group (CCG) study Blood 82 1993 54a
15. Dinndorf P Bunin N Bone marrow transplantation for children with acute myelogenous leukemia American Journal of Pediatric Hematology and Oncology 17 1995 211 224
16. Estey E Keating MJ McCredie KB Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemia Leukemia 4 1990 95 99
17. Estey E Plunkett W Gandhi V Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia Leukemia and Lymphoma 9 1993 343 350
18. Estey E Thall P Andreeff M Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor Journal of Clinical Oncology 12 1994 671 678
19. Gandhi V Estey E Keating MJ Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia Journal of Clinical Oncology 11 1993 116 124
20. Grier HE Gelber RD Link MP Intensive, sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035 and HI-C-Daze Leukemia 6 1992 48 51
21. Hakami N Look AT Steuber PC Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group study Journal of Clinical Oncology 5 1987 1022 1025
22. Heinemann V Murray D Walters R Mitoxantrone-induced DNA damage in leukemia cells is enhanced by treatment with high-dose arabinosylcytosine Cancer Chemotherapy and Pharmacology 22 1988 205 210
23. Hongo T Fujii Y Igarashi Y An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia Cancer 65 1990 1263 1272
24. Hurwitz CA Raimondi SC Head D Distinctive immunophenotypic features of t(8;21) (q22; q22) acute myeloblastic leukemia in children Blood 80 1992 3182 3188
25. Iizuka Aiso M Oshimi K Myeloblastoma formation in acute myeloid leukemia Leukemia Research 16 1992 665 671
26. Iselius L Jacobs P Morton N Leukaemia and transient leukaemia in Down Syndrome Human Genetics 85 1990 477 485
27. Jahns-Streubel G Unterhalt M Schleyer E Correlation of deoxycytidine deaminase, thymidine kinase and polymerase alpha activity and deoxycytidine deaminase gene expression in vivo with clinical response to TAD-9 + GM-CSF induction therapy in acute myeloid leukemia Annals of Hematology 70 1995 119a
28. Kalwinsky D Mirro J Schell M Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five drug regimen including etoposide Journal of Clinical Oncology 6 1988 1134 1143
29. Kalwinsky D Raimondi S Schell MJ Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia Journal of Clinical Oncology 8 1990 75 83
30. Kaspers GJL Kardos G Pieters R Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report Leukemia 8 1994 1224 1229
31. Kaspers GJL Veerman AJP Pieters R In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubin in untreated childhood acute leukemia Leukemia 8 1994 24 29
32. abstract No. 02 Klumper E Ossenkoppele GJ Pieters R The clinical relevance of in vitro resistance to cytosine arabinoside in acute myeloid leukemia determined by the MTT assay Leukemia 9 1995 528
33. Kojima S Kato K Itisayamo T Favorable treatment outcome in children with acute myeloid leukemia and Down Syndrome Blood 81 1993 3164
34. Kuss BJ Deeley RG Cole SPC Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion of chromosome 16: prognostic implications Lancet 343 1994 1531 1534
35. abstract 216 Lampkin B Wells R Wood W Preliminary results: Transplantation (BMT) vs. intensification chemotherapy (Itf) and maintenance chemotherapy (M) vs. no M in childhood acute nonlymphocytic leukemia (AML) Proceedings of the American Society of Clinical Oncology 1990
36. Levitt GA Stiller CA Chessells JM Prognosis of Down syndrome with acute leukemia Archives of Diseases of Childhood 65 1990 212 216
37. Lockhart S Plunkett W Cesha S High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia Journal of Clinical Oncology 12 1994 587 595
38. Marie JP P. Glycoprotein in Adult Hematologic malignancies Hematology/Oncology Clinics of North America 9 1995 239 268
39. Miller RW Frequency and Environmental epidemiology of childhood cancer Pizzo PA Poplack DG Principles and practice of Pediatric Oncology 1989 J.B. Lippincott Philadelphia 3 18
40. Nesbit ME Jr Buckley JD Feig SA Chemotherapy for induction of remission of Childhood Acute Myeloid Leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Children's Cancer Group Journal of Clinical Oncology 12 1994 127 135
41. Newman EM Villacorte DG Testi AM Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study Cancer Chemotherapy and Pharmacology 27 1990 60 66
42. Nguyen C Mattei NG Mattei JF Localization of the human NCAM gene to band q23 of chromosome 11 Journal of Cellular Biology 102 1986 711 715
43. Novakovic B US childhood cancer survival, 1973–1987 Medical and Pediatric Oncology 23 1994 480 486
44. abstract No. 0-149 Ortega JJ Olive T Diaz de Heredia C High-lights of ANLL therapy in Spain Medical and Pediatric Oncology 25 1995 271
45. Pui CH Dahl GV Kalwinsky DK Central nervous system leukemia in children with acute nonlymphoblastic leukemia Blood 66 1985 1062 1067
46. Pui CH Kalwinsky DK Schell MJ Acute nonlymphoblastic leukemia in infants: Clinical presentation and outcome Journal of Clinical Oncology 6 1988 1008 1013
47. Pui C-H Behm FG Raimondi SC Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia New England Journal of Medicine 321 1989 136 142
48. Ramilo-Torno LV Avramis VI Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines Cancer Chemotherapy and Pharmacology 35 1995 191 199
49. Ravindranath Y Steuber CP Krischer J High dose cytosine arabinoside for intensification of early therapy in childhood acute myeloid leukemia: a pediatric oncology group study Journal of Clinical Oncology 9 1991 572 580
50. Ravindranath Y Abella E Krischer JP Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 Blood 80 1992 2210 2214
51. abstract No. 9 Ravindranath Y Abella E Krischer J Superior outcome in Down's Syndrome with AML: possible link between sensitivity to methotrexate and response to cytosine arabinoside Medical and Pediatric Oncology 20 1992 373
52. abstract No. 148 Ravindranath Y Chang M Gresik M Intensive consolidation chemotherapy (ICT) vs. autologous bone marrow transplantation (ABMT) in first remission of childhood AML: experience on pediatric oncology group study-POG 8821 Medical and Pediatric Oncology 25 1995 271
53. Reid JM Pendergrass TW Krailo MD Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Children's Cancer Study Group report Cancer Research 50 1990 6525 6528
54. Ritter J Vormoor J Creutzig U Schellong G Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-FBM-78 and -83 Medical and Pediatric Oncology 17 1989 202 209
55. Ritter J Creutszig U Schellong G Treatment results of three consecutive German childhood AML trials Leukemia 6 supplement 2 1992 59 62
56. abstract No. 2418a Robertson L Gandhi V Nowak B Plunkett W Enhancement of arabinofuranosylcytosine (ara-c) phosphorylation by pretreatment with arabinofuranosyl-2-fluoroadenine (F-ara-A) and deazauridine (DAU) in human leukemia cells Proceedings of the American Association for Cancer Research 31 1990 407
57. Robison L Down syndrome and leukemia Leukemia 6 supplement 1 1992 5 7
58. Rutishauser U Acheson A Hall AK Mann DM Schoenshein J The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions Science 240 1988 53 57
59. Saachii N Down Syndrome and chromosome 21 abnormalities Baillière's Clinics in Haematology 5 1992 815 831
60. Sanders JK Thomas ED Buckner DC Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update Blood 66 1985 460 462
61. Santana VM Mirro J Jr Harwood FC A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia Journal of Clinical Oncology 9 1991 416 422
62. Santana VM Mirro J Jr Kearns C 2-chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia Journal of Clinical Oncology 10 1992 364 370
63. Santana VM Hurwitz CA Blakley RL Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia Blood 84 1994 1237 1242
64. abstract No. 1266 Sato JK Wiersma S Krailo M Phase I clinical and pharmacodynamic study of continuous infusion (CI) fludarabine followed by continuous infusion (CI) cytosine arabinoside (ara-C) in relapsed leukemia Proceedings of the American Association for Cancer-Research 33 1992 211
65. abstract No. 1196 Sievers EL Smith FO Lee JW Cell surface expression of the multidrug resistance p-glycoprotein (P-170) in pediatric acute myeloid leukemia fails to define a poor prognostic group Blood 84 1994 303
66. abstract Slordahl SH Gustaffsson G Komundson G Down's Syndrome (DS) and acute myelogenous leukemia (AML). A population based study in the five Nordic countries Medical and Pediatric Oncology 20 No. 10 1992 373
67. abstract Stahnke K Ritter J Boos J Ursula C Mitoxantrone-etoposide or HD-Ara-C/Mitoxantrone therapy for remission induction in children with first relapse of AML Annals of Hematology 68 No. 126 1994 32
68. Steuber CP Culbert SJ Ravindranath Y Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group Experience (1977–1988) Haematology and Blood Transfusion 33 1990 198 209
69. Steuber CP Civin C Ruymann F Therapy of childhood acute nonlymphocytic leukemia (ANLL): a Pediatric Oncology Group Study (POG 8101) Journal of Clinical Oncology 9 1991 247 258
70. Steuber P Holbrook T Camitta B Induction treatment of refractory or recurrent childhood AML using amsacrine and etoposide with or without 5-azacitidine: a phase II Pediatric Oncology Group study Proceedings of the American Society of Clinical Oncology 13 No. 1044 1994 318 abstract
71. Stevens M Hann I Wheatley K Gray R Improved outcome in paediatric acute myeloid leukaemia (AML): results of the United Kingdom Medical Research Council (MRC) AML10 trial Proceedings of American Society of Clinical Oncology 14 No. 1036 1995 343 abstract
72. Tallman MS Hakimi A Shah JM Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia Journal of Clinical Oncology 11 1993 690 697
73. Tan C Steinherz P Meyers P Idarubicin in combination with high dose cytosine arabinoside in patients with acute leukemia in relapse Proceedings of the American Association for Cancer Research 31 No. 1133 1990 191 abstract
74. Taub JW & Ravindranath Y (in press) Superior disease free survival of Down Syndrome children with acute myeloid leukemia associated with enhanced sensitivity to cytarabine and daunorubicin—a hypothesis. Proceedings of the Tenth Annual National Down Syndrome Society Science Research Conference .
75. (in press) Taub JW Matherly LH Buck SA Enhanced metabolism of 1-β- d -arabinofuranosylcytosine in Down Syndrome cells: a contributing factor to the event free survival of Down Syndrome children with acute myeloid leukemia Blood 1996
76. Tiedemann K Waters K Tauro G Results of intensive therapy in childhood acute myeloid leukemia incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission Blood 82 1993 3730 3738
77. abstract van den Heuvel-Eibrink MM te Boekhorst PAW van Kapel J Mechanisms of drug resistance in childhood acute myeloid leukemia Blood 82 No. 2185 1993 550a
78. Weinstein HJ Maher RJ Rosenthal DS Treatment of acute myelogenous leukemia in adults and children New England Journal of Medicine 303 1980 473 478
79. Weinstein HJ Mayer RH Rosenthal DS Chemotherapy for acute myelogenous leukemia in children and adults. VAPA update Blood 62 1983 315 319
80. Wells RJ Odom LF Gold SH Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance Gene 1 Medical and Pediatric Oncology 22 1994 244 249
81. Windebank KP Tefferi A Smithson WA Acute megakaryocytic leukemia (M7) in children Mayo Clinic Proceedings 64 1989 1339 1351
82. Woods WG Ruymann FB Lampkin BC The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia Cancer 66 1990 1106 1113
83. Woods WG Kobrinsky N Buckley S Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Children's Cancer Group pilot study Journal of Clinical Oncology 11 1993 1448 1457
84. (abstract) Woods WG Kobrinsky N Buckley J Timing intensive induction therapy improves postremission outcome in acute myeloid leukemia (AML) irrespective of the use of bone marrow transplantation (BMT) Blood 84 912 1994 232
85. Zipursky A Peeters M Poon A Megakaryoblastic leukemia and Down's Syndrome: a review Progress in Clinical and Biological Research 246 1987 33 56
86. Zipursky A Thorner P Harven ED Myelodysplasia and acute megakaryoblastic leukemia in Down's Syndrome Leukemia Research 18 1994 163 171